Q4 2024 Management View Mario Leão, CEO, highlighted the company's net income of BRL 3.87 billion for Q4 2024 and emphasized a 17.6% growth in profitability on a quarterly basis. He noted strong net ...
47mon MSN
Q2 2025 Management View CEO Kim Kelderman highlighted 9% organic revenue growth for the quarter, driven by strong performance in biopharma end markets, particularly large pharma, which benefited GMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback